Due to the close relationship among CAFs, cancer progression, and the TGF-β signaling pathway, we used SB431542 to block the TGF-β signaling pathway in BCCs, which verified that the migration and invasion abilities of BCCs in the CAV-1-deficient microenvironment were reversed after treament with SB431542. The gene discussed is TGFB1; the disease is cancer.